Emergence and epidemiology of vancomycin-resistant enterococci in Australia
DOI:
https://doi.org/10.33321/cdi.1998.22.57Keywords:
vancomycin-resistant enterococci (VRE)Abstract
Enterococci with acquired resistance to vancomycin and other glycopeptides (VRE) have emerged and spread rapidly through Europe and the United States since 1988. The first isolate of VRE in Australia occurred in 1994. Only one case was noted in 1995. Since March 1996 there has been a steady increase in the number of reports of VRE throughout the country. To August 1998 there have been 69 documented strains or clusters of strains detected in patients with documented infection, and about 3 times as many strains have been detected through screening procedures of contacts or in risk groups. 19% of strains whose source was known were blood isolates, while 34% came from urine and 47% came from other specimens. The strains have been found in 26 institutions in 10 widely separated cities or regions of the country (in 6/8 states or territories), without any obvious temporal associations in their appearance. All strains appear to have arisen locally except for one strain imported from the United Kingdom. Furthermore there was no direct evidence of inter-hospital transfer of strains. All clinical strains were examined by PCR to confirm species and to test for the presence of known vancomycin-resistance genes. Of the 69 strains, 42 were vanB E. faecium, 12 were vanA E. faecium, 9 were vanB E. faecalis, 3 were vanA E. faecalis. Three were negative for vanA, vanB, vanC1, vanC2/C3 and vanD. PGFE profiles on 38 strains have revealed at least 8 types of vanB E. faecium, 6 of vanA E. faecium, 4 of vanB E. faecalis and 2 of vanA E. faecalis. Isolates containing vanA always had different profiles from those containing vanB. Clinical clustering was confirmed by PFGE, and supported by extended antibiogram. 14 of 15 E. faecalis were ampicillin susceptible compared to only 2 of 54 E. faecium. One E. faecalis strain was beta-lactamase positive. The epidemiology of VRE in Australia appears to be different from that of Europe or the United States, since vanB E. faecium predominates and strains have appeared in diverse locations independently and are highly polyclonal. Commun Dis Intell 1998;22:249-252.
Downloads
References
Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR Weekly Rep. 1993;42:597-599.
Leclercq R, Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis 1997;24:545-546.
Aarestrup FM, Ahrens P, Madsen M, Pallesen LV, Poulsen RL,Westh H. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within VanA cluster. Antimicrob Agents Chemother. 1996;40:1938-1940.
Kamarulzaman A, Tosolini FA, Boquest AL, Geddes JE, Richards MJ. Vancomycin-resistant Enterococcus faecium in a liver transplant recipient [abstract]. Aust N Z J Med 1995;25:560.
Branley J, Yan B, Benn RAV. Vancomycin-resistant Enterococcus faecalis [letter]. Med J Aust 1996;165:292.
Faoagali J, Bodman J, Geary A. Isolation of vancomycin-resistant enterococci in Queensland, case 2. Commun Dis Intell 1996;20:402-403.
Ferguson J, Butt H, Johnson C, Boyle M. Vancomycin-resistant Enterococcus faecium colonisations [letter]. Med J Aus t. 1996;165:292-293.
Paterson D, Jennings A, Allen A, Sherlock K, Whitby M. Isolation of vancomycin-resistant enterococci in Queensland, case 1. Commun Dis Intell 1996;20:400-401.
Bell JM, Paton JC, Turnidge J. Emergence of Vancomycin-resistant enterococci in Australia: Phenotypic and genotypic characteristics of isolates. J Clin Microbiol. 1998;36:2187-2190.
Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 1989;27:731-734
Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol. 1995;33:24-27. (Erratum, 33:1434)
National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
Perichon B, Reynolds P, Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother. 1997;41:2016-2018.
Tenover FC, Arbeit RD, Goering RV, Mickelsen P, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-2239.
Hayden MK, Trenholme GM, Schultz JE, Sahm DF. In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J Infect Dis. 1993;167:1224-1227.
Downloads
Published
How to Cite
License
Copyright (c) 1998 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
